相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
Steven Fishbane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Morphine-induced respiratory depression is independent of β-arrestin2 signalling
Andrea Kliewer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Reed M. Stein et al.
NATURE (2020)
Nanobody-enabled monitoring of kappa opioid receptor states
Tao Che et al.
NATURE COMMUNICATIONS (2020)
Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys
S. L. Huskinson et al.
PSYCHOPHARMACOLOGY (2020)
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis et al.
SCIENCE SIGNALING (2020)
An open-source drug discovery platform enables ultra-large virtual screens
Christoph Gorgulla et al.
NATURE (2020)
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Reid H. J. Olsen et al.
NATURE CHEMICAL BIOLOGY (2020)
Advances in therapeutic peptides targeting G protein-coupled receptors
Anthony P. Davenport et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Determination of the melanocortin-4 receptor structure identifies Ca2+ as a cofactor for ligand binding
Jing Yu et al.
SCIENCE (2020)
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion
Jeffrey J. Liu et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Prevalence and Profile of High-Impact Chronic Pain in the United States
Mark H. Pitcher et al.
JOURNAL OF PAIN (2019)
Ultra-large library docking for discovering new chemotypes
Jiankun Lyu et al.
NATURE (2019)
Structural insights into the activation of metabotropic glutamate receptors
Antoine Koehl et al.
NATURE (2019)
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Terakado Kimura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist
M. Alexander Stanczyk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
β-Fluorofentanyls Are pH-Sensitive Mu Opioid Receptor Agonists
Ricardo Rosas et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response
Besma Benredjem et al.
NATURE COMMUNICATIONS (2019)
An amygdalar neural ensemble that encodes the unpleasantness of pain
Gregory Corder et al.
SCIENCE (2019)
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects
A. Kliewer et al.
NATURE COMMUNICATIONS (2019)
Role of signalling molecules in behaviours mediated by the delta opioid receptor agonist SNC80
Isaac J. Dripps et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Tao Che et al.
CELL (2018)
Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets
Dahlia R. Weiss et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Na+-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1
Tetsuya Hori et al.
NATURE CHEMICAL BIOLOGY (2018)
Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits
Dong Wang et al.
NEURON (2018)
Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor
Magdalena Korczynska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
In vivo brain GPCR signaling elucidated by phosphoproteomics
Jeffrey J. Liu et al.
SCIENCE (2018)
Structural Basis for G Protein-Coupled Receptor Signaling
Sarah C. Erlandson et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 47 (2018)
The Molecular Basis of G Protein-Coupled Receptor Activation
William I. Weis et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats
C. Austin Zamarripa et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
New concepts in opioid analgesia
Christoph Stein
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Structural insights into G-protein-coupled receptor allostery
David M. Thal et al.
NATURE (2018)
Structure of the μ-opioid receptor-Gi protein complex
Antoine Koehl et al.
NATURE (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Manifold roles of beta-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9
Louis M. Luttrell et al.
SCIENCE SIGNALING (2018)
G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons
Jo-Hao Ho et al.
SCIENCE SIGNALING (2018)
A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates
Huiping Ding et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016
James Dahlhamer et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Advances in Achieving Opioid Analgesia Without Side Effects
Halina Machelska et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeting multiple opioid receptors - improved analgesics with reduced side effects?
Thomas Guenther et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents
Ahmad A. Altarifi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
In silico design of novel probes for the atypical opioid receptor MRGPRX2
Katherine Lansu et al.
NATURE CHEMICAL BIOLOGY (2017)
The Role of Science in Addressing the Opioid Crisis
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A nontoxic pain killer designed by modeling of pathological receptor conformations
V. Spahn et al.
SCIENCE (2017)
D4 dopamine receptor high-resolution structures enable the discovery of selective agonists
Sheng Wang et al.
SCIENCE (2017)
Polyglycerol-opioid conjugate produces analgesia devoid of side effects
Sara Gonzalez-Rodriguez et al.
ELIFE (2017)
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid et al.
CELL (2017)
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice
Joanna Starnowska et al.
ACS CHEMICAL NEUROSCIENCE (2017)
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker et al.
CELL (2017)
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor
Selena S. Schattauer et al.
CELLULAR SIGNALLING (2017)
Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors
Yi Shang et al.
ACS CHEMICAL BIOLOGY (2016)
Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys
Kaoru Nakao et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
Tarsis F. Brust et al.
SCIENCE SIGNALING (2016)
New Technologies for Elucidating Ooioid Receptor Function
Michael R. Bruchas et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
Tarsis F. Brust et al.
SCIENCE SIGNALING (2016)
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists
Amy E. Foxx-Orenstein
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Contribution of the respiratory network to rhythm and motor output revealed by modulation of GIRK channels, somatostatin and neurokinin-1 receptors
Gaspard Montandon et al.
SCIENTIFIC REPORTS (2016)
Ligand-Based Discovery of a New Scaffold for Allosteric Modulation of the μ-Opioid Receptor
Paola Bisignano et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Discovery, Synthesis, and Molecular Pharmacology of Selective Positive Allosteric Modulators of the δ-Opioid Receptor
Neil T. Burford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons
Jonathan M. Ehrich et al.
JOURNAL OF NEUROSCIENCE (2015)
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65
Xi-Ping Huang et al.
NATURE (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
Structural basis for bifunctional peptide recognition at human δ-opioid receptor
Gustavo Fenalti et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus
Jenny Morgenweck et al.
NEUROPHARMACOLOGY (2015)
NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
Casey O'Connor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Structural basis for bifunctional peptide recognition at human δ-opioid receptor
Gustavo Fenalti et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks
Eric Erbs et al.
BRAIN STRUCTURE & FUNCTION (2015)
Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications
N. T. Burford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The G Protein-Biased kappa-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo
Kate L. White et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation
Celeste B. Burness et al.
DRUGS (2014)
Molecular control of δ-opioid receptor signalling
Gustavo Fenalti et al.
NATURE (2014)
Transmitting Pain and Itch Messages: A Contemporary View of the Spinal Cord Circuits that Generate Gate Control
Joao Braz et al.
NEURON (2014)
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
William D. Chey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Identification of Novel Functionally Selective κ-Opioid Receptor Scaffolds
Kate L. White et al.
MOLECULAR PHARMACOLOGY (2014)
Novel 6β-acylaminomorphinans with analgesic activity
Andras Varadi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists
Eyal Vardy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Discovery of a Novel Selective Kappa-Opioid Receptor Agonist Using Crystal Structure-Based Virtual Screening
Ana Negri et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain
Alexander T. Podolsky et al.
LIFE SCIENCES (2013)
Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity
Ivone Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines
Scott M. DeWire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Mu Opioids and Their Receptors: Evolution of a Concept
Gavril W. Pasternak et al.
PHARMACOLOGICAL REVIEWS (2013)
Building a Better Analgesic: Multifunctional Compounds that Address Injury-Induced Pathology to Enhance Analgesic Efficacy while Eliminating Unwanted Side Effects
T. M. Largent-Milnes et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue
Anja Schreiter et al.
FASEB JOURNAL (2012)
Structure of the δ-opioid receptor bound to naltrindole
Sebastien Granier et al.
NATURE (2012)
Structure of the human κ-opioid receptor in complex with JDTic
Huixian Wu et al.
NATURE (2012)
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Aaron A. Thompson et al.
NATURE (2012)
Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
Aashish Manglik et al.
NATURE (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
Allen W. Mangel et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2012)
Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia
Claire Gaveriaux-Ruff et al.
PAIN (2011)
Kinase cascades and ligand-directed signaling at the kappa opioid receptor
Michael R. Bruchas et al.
PSYCHOPHARMACOLOGY (2010)
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety
Takashi Yamamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Cellular and Molecular Mechanisms of Pain
Allan I. Basbaum et al.
CELL (2009)
Antinociceptive Effects of Nociceptin/Orphanin FQ Administered Intrathecally in Monkeys
Mei-Chuan Ko et al.
JOURNAL OF PAIN (2009)
Behavioral Effects of a Synthetic Agonist Selective for Nociceptin/Orphanin FQ Peptide Receptors in Monkeys
Mei-Chuan Ko et al.
NEUROPSYCHOPHARMACOLOGY (2009)
μ-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system
Ying Li et al.
JOURNAL OF NEUROSCIENCE (2008)
The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system
Benjamin B. Land et al.
JOURNAL OF NEUROSCIENCE (2008)
Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2
Michael R. Bruchas et al.
NEUROREPORT (2008)
Stress-induced p38 mitogen-activated protein kinase activation mediates κ-opioid-dependent dysphoria
Michael R. Bruchas et al.
JOURNAL OF NEUROSCIENCE (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-dependent in neurons and astrocytes
Michael R. Bruchas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
κ-opioid system in uremic pruritus:: Multicenter, randomized, double-blind, placebo-controlled clinical studies
B Wikström et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism
SM Husbands et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Pain management by a new series of dual inhibitors of enkephalin degrading enzymes:: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone
S Le Guen et al.
PAIN (2003)
Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor
DJ Sheffler et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist
BL Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
LM Luttrell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
